Management of surplus drugs in a large tertiary hospital
10.3760/cma.j.cn111325-20240103-00008
- VernacularTitle:某大型三级医院结余药品管理实践
- Author:
Dongyan LI
1
;
Wei FU
;
Lin QIU
;
Guangjie WU
;
Fanxue XIN
;
Jianling ZHENG
;
Xiaozhe DAI
;
Qian CHEN
;
Yan LIU
;
Li TAN
;
Dong LIU
;
Juan LI
Author Information
1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- Keywords:
Surplus drug;
Pharmaceutical management;
Fractional dose billing;
Agreed pricing unit;
Management process;
Medical insurance funds
- From:
Chinese Journal of Hospital Administration
2024;40(6):448-453
- CountryChina
- Language:Chinese
-
Abstract:
To standardize the management of surplus drugs, improve the efficiency of medical resource utilization, promote the rational use of medical insurance funds, and reduce the financial burden on patients, a large tertiary hospital implemented a practice for managing surplus drugs starting in May 2023. This practice encompassed multiple aspects, including the establishment of organizational structure, clarification of responsibilities, formulation of billing for fractional doses and a reasonable surplus drugs list, establishment of standardized management processes, and allocation of special funds for surplus drugs. These efforts had initially achieved effective management of surplus drugs. As of November 2023, the management of surplus drugs had benefited 136 908 patients, with an average savings of 873.61 yuan per patient and a cumulative savings of approximately 34.7 million yuan in medical insurance funds. This practice had effectively reduced the wastage of medical resources, and could provide references for promoting standardized management of surplus drugs in medical institutions of China. In the future, the hospital should further expand the coverage of surplus drugs, ensure patients′ rights to informed consent, and establish a comprehensive performance incentive mechanism to promote the sustainable development of surplus drug management.
